160 related articles for article (PubMed ID: 10548491)
1. The synergistic transactivation of the hepatitis B viral (HBV) pregenomic promoter by the E6 protein of human papillomavirus type 16 (HPV-16 E6) with HBV X protein was mediated through the AP1 site of E element in the enhancer I (EnI) in human liver cell.
Lee DH; Choi BH; Rho HM
Biochem Biophys Res Commun; 1999 Nov; 265(1):62-6. PubMed ID: 10548491
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
Kyo S; Tam A; Laimins LA
Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
[TBL] [Abstract][Full Text] [Related]
3. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
4. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes.
Medina-Martínez O; Vallejo V; Guido MC; García-Carrancá A
Mol Carcinog; 1997 Jun; 19(2):83-90. PubMed ID: 9210955
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor of activated T cells (NFAT1-C) represses the enhancer II and pregenomic promoter (EnII/Cp) of hepatitis B virus (HBV) through its responsive site GGAGA and nullifies the HBx-driven transcriptional activation.
Lee JH; Rho HM
IUBMB Life; 2001 Apr; 51(4):255-61. PubMed ID: 11569920
[TBL] [Abstract][Full Text] [Related]
6. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
7. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.
Patel D; Huang SM; Baglia LA; McCance DJ
EMBO J; 1999 Sep; 18(18):5061-72. PubMed ID: 10487758
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the role of individual protein binding motifs within the hepatitis B virus enhancer I on X promoter activity using linker scanning mutagenesis.
Gustin K; Shapiro M; Lee W; Burk RD
Virology; 1993 Apr; 193(2):653-60. PubMed ID: 8384750
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
[TBL] [Abstract][Full Text] [Related]
10. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.
Kekulé AS; Lauer U; Meyer M; Caselmann WH; Hofschneider PH; Koshy R
Nature; 1990 Feb; 343(6257):457-61. PubMed ID: 2153938
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
Kwon JA; Rho HM
Biol Chem; 2003 Feb; 384(2):203-12. PubMed ID: 12675512
[TBL] [Abstract][Full Text] [Related]
12. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state.
Wollersheim M; Debelka U; Hofschneider PH
Oncogene; 1988 Nov; 3(5):545-52. PubMed ID: 2856254
[TBL] [Abstract][Full Text] [Related]
13. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.
Kekulé AS; Lauer U; Weiss L; Luber B; Hofschneider PH
Nature; 1993 Feb; 361(6414):742-5. PubMed ID: 8441471
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA].
Ma CH; Sun WS; Liu SX; Wang XY; Zhang LN; Cao YL; Han LH
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):291-4. PubMed ID: 12773245
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of hepatitis B virus transactivator X: implication of the leucine zipper-like region and C-terminal seven conserved amino acids in functional regions.
Kim YH; Kang SK; Lee YI
Biochem Biophys Res Commun; 1993 Dec; 197(2):894-903. PubMed ID: 8267629
[TBL] [Abstract][Full Text] [Related]
17. Insulin activates the hepatitis B virus X gene through the activating protein-1 binding site in HepG2 cells.
Choi BH; Park CJ; Rho HM
DNA Cell Biol; 1998 Nov; 17(11):951-6. PubMed ID: 9839804
[TBL] [Abstract][Full Text] [Related]
18. Viral interaction: a possible contributing factor in head and neck cancer progression.
Underbrink MP; Hoskins SL; Pou AM; Albrecht T
Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
[TBL] [Abstract][Full Text] [Related]
19. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter.
Choi M; Lee H; Rho HM
IUBMB Life; 2002 Jun; 53(6):309-17. PubMed ID: 12625370
[TBL] [Abstract][Full Text] [Related]
20. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication.
Nakatake H; Chisaka O; Yamamoto S; Matsubara K; Koshy R
Virology; 1993 Aug; 195(2):305-14. PubMed ID: 8337816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
